These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9509760)

  • 1. Murine B lymphopoiesis: towards a unified model.
    Osmond DG; Rolink A; Melchers F
    Immunol Today; 1998 Feb; 19(2):65-8. PubMed ID: 9509760
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro analysis of murine B-cell development.
    Whitlock C; Denis K; Robertson D; Witte O
    Annu Rev Immunol; 1985; 3():213-35. PubMed ID: 3904770
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow B cell development.
    Vogler LB
    Clin Haematol; 1982 Oct; 11(3):509-29. PubMed ID: 6756732
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of B-cell abnormalities in autoimmune mice by in vitro culture system using two types of bone marrow stromal cell clone.
    Ohmori J; Ezaki T; Kotani M
    Immunology; 1990 Dec; 71(4):544-50. PubMed ID: 2279739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymphopoiesis supported by osteolineage cells].
    Katayama Y
    Clin Calcium; 2016 May; 26(5):707-12. PubMed ID: 27117616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors.
    Stephan RP; Lill-Elghanian DA; Witte PL
    J Immunol; 1997 Feb; 158(4):1598-609. PubMed ID: 9029095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microenvironmental niches in the bone marrow required for B-cell development.
    Nagasawa T
    Nat Rev Immunol; 2006 Feb; 6(2):107-16. PubMed ID: 16491135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 7 independent development of human B cells.
    Prieyl JA; LeBien TW
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10348-53. PubMed ID: 8816803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and molecular requirements for B lymphopoiesis.
    Gimble JM; Hayashi S; Pietrangeli CE; Lee G; Kincade PW
    Adv Exp Med Biol; 1989; 254():69-75. PubMed ID: 2683609
    [No Abstract]   [Full Text] [Related]  

  • 10. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice.
    You-Ten KE; Muise ES; Itié A; Michaliszyn E; Wagner J; Jothy S; Lapp WS; Tremblay ML
    J Exp Med; 1997 Aug; 186(5):683-93. PubMed ID: 9271584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo.
    Prazma CM; Yazawa N; Fujimoto Y; Fujimoto M; Tedder TF
    J Immunol; 2007 Oct; 179(7):4550-62. PubMed ID: 17878352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interleukin-7 receptor alpha chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis.
    Corcoran AE; Smart FM; Cowling RJ; Crompton T; Owen MJ; Venkitaraman AR
    EMBO J; 1996 Apr; 15(8):1924-32. PubMed ID: 8617239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule.
    Engel P; Zhou LJ; Ord DC; Sato S; Koller B; Tedder TF
    Immunity; 1995 Jul; 3(1):39-50. PubMed ID: 7542548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicolor immunophenotyping: human immune system hematopoiesis.
    Wood B
    Methods Cell Biol; 2004; 75():559-76. PubMed ID: 15603442
    [No Abstract]   [Full Text] [Related]  

  • 15. Positive and negative selection of antibody repertoires during B-cell differentiation.
    Grandien A; Modigliani Y; Freitas A; Andersson J; Coutinho A
    Immunol Rev; 1994 Feb; 137():53-89. PubMed ID: 7518414
    [No Abstract]   [Full Text] [Related]  

  • 16. B lymphopoiesis in the mouse.
    Rolink A; Melchers F
    Adv Immunol; 1993; 53():123-56. PubMed ID: 8512034
    [No Abstract]   [Full Text] [Related]  

  • 17. In-vitro models of stroma-dependent lymphopoiesis.
    Péault B
    Semin Immunol; 1995 Jun; 7(3):169-75. PubMed ID: 7579203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 as systemic modifier of B lymphopoiesis. Recombinant IL-1 alpha binds to stromal cells and sinusoid endothelium in bone marrow and precursor B cell dynamics.
    Fauteux LJ; Osmond DG
    J Immunol; 1996 Apr; 156(7):2376-83. PubMed ID: 8786294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19
    McBride JD; Liu X; Berry WL; Janknecht R; Cheng R; Zhou K; Badiavas EV; Ma JX
    Int J Hematol; 2017 Jun; 105(6):748-757. PubMed ID: 28299632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CC11: a monoclonal antibody specific for interleukin 3-sensitive mouse cells defines two major populations of B cell precursors in the bone marrow.
    Palacios R; Leu T
    Immunol Rev; 1986 Oct; 93():125-46. PubMed ID: 3491035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.